Sweden · Delayed Price · Currency is SEK Dextech Medical AB Statistics
Total Valuation
XSAT:DEX has a market cap or net worth of SEK 188.56 million. The enterprise value is 179.92 million.
| Market Cap | 188.56M |
| Enterprise Value | 179.92M |
Important Dates
The next confirmed earnings date is Sunday, November 1, 2026.
| Earnings Date | Nov 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XSAT:DEX has 18.49 million shares outstanding. The number of shares has decreased by -0.96% in one year.
| Current Share Class | 18.49M |
| Shares Outstanding | 18.49M |
| Shares Change (YoY) | -0.96% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.97% |
| Owned by Institutions (%) | n/a |
| Float | 8.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 10.30 |
| P/TBV Ratio | 10.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.02
| Current Ratio | 14.02 |
| Quick Ratio | 13.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.00% and return on invested capital (ROIC) is -19.29%.
| Return on Equity (ROE) | -30.00% |
| Return on Assets (ROA) | -18.86% |
| Return on Invested Capital (ROIC) | -19.29% |
| Return on Capital Employed (ROCE) | -36.32% |
| Weighted Average Cost of Capital (WACC) | 11.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -6.46M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.00% in the last 52 weeks. The beta is 1.31, so XSAT:DEX's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +20.00% |
| 50-Day Moving Average | 10.18 |
| 200-Day Moving Average | 10.13 |
| Relative Strength Index (RSI) | 53.69 |
| Average Volume (20 Days) | 6,173 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.65M |
| Pretax Income | -6.46M |
| Net Income | -6.46M |
| EBITDA | -6.49M |
| EBIT | -6.65M |
| Earnings Per Share (EPS) | -0.35 |
Balance Sheet
The company has 8.63 million in cash and no debt, with a net cash position of 8.63 million or 0.47 per share.
| Cash & Cash Equivalents | 8.63M |
| Total Debt | n/a |
| Net Cash | 8.63M |
| Net Cash Per Share | 0.47 |
| Equity (Book Value) | 18.30M |
| Book Value Per Share | 0.99 |
| Working Capital | 8.47M |
Cash Flow
| Operating Cash Flow | -1.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 158,181 |
| Net Borrowing | n/a |
| Free Cash Flow | -1.07M |
| FCF Per Share | -0.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XSAT:DEX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.96% |
| Shareholder Yield | 0.96% |
| Earnings Yield | -3.43% |
| FCF Yield | -0.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |